| 股票代码 | 002007 | 当期评分 | ||||
| 股票名称 | 华兰生物 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 1.3898 | 0.9713 | 0.3098 | 0.3098 | 0.3098 | ✘ |
| 销售净利润率(%) | 37.5995 | 37.2675 | 34.7574 | 34.7574 | 34.7574 | ✔ |
| 销售毛利率(%) | 64.1061 | 64.1017 | 67.1382 | 67.1382 | 67.1382 | ✔ |
| 净资产收益率(%) | 20.62 | 19.62 | 13.85 | 13.85 | 13.85 | ✘ |
| 营业增长率(%) | 35.8386 | 15.0158 | 16.4626 | 16.4626 | 16.4626 | ✘ |
| 净利润增长率(%) | 50.4969 | 14.0003 | 5.1322 | 5.1322 | 5.1322 | ✘ |
| 每股收益(%) | 1.2252 | 0.9148 | 0.5286 | 0.2805 | 0.1762 | ✔ |
| 现金流量比率(%) | 179.4161 | 196.2284 | 39.6239 | 48.9089 | 14.4992 | ✔ |
| 三项费用比重(%) | 22.3887 | 20.0489 | 23.673 | 13.7281 | 13.0988 | ✔ |
| 每股净资产(¥) | 5.9427 | 4.6635 | 3.8155 | 3.5657 | 4.8425 | ✔ |
| 流动比率(%) | 6.6378 | 8.1859 | 4.6079 | 5.9515 | 8.8409 | ✔ |
| 速动比率(%) | 4.9672 | 6.5161 | 3.7758 | 4.6618 | 7.1132 | ✔ |
| 现金比率(%) | 59.391 | 153.1408 | 29.2671 | 100.7774 | 100.7774 | ✔ |
| 总资产利润率(%) | 20.654 | 19.5915 | 13.0117 | 6.5658 | 3.0886 | ✔ |
| 主营利润比重% | 148.3767 | 147.2904 | 159.0722 | 136.2161 | 140.6013 | ✔ |
| 应收账款(万元) | 90,973.27 | 96,463.06 | 160,267.08 | 71,297.26 | 108,512.58 | ✔ |
| 应收票据(万元) | 16,952.93 | 15,618.16 | 28,559.95 | 20,155.06 | 11,616.02 | ✘ |
| 预付款项(万元) | 2,503.53 | 1,985.15 | 6,963.06 | 3,773.12 | 5,511.11 | ✔ |
| 存货(万元) | 120,358.94 | 115,957.36 | 118,711.19 | 124,406.34 | 114,254.37 | ✔ |
| 在建工程(万元) | 22,540.49 | 10,980.98 | 30,143.06 | 17,852.89 | 13,589.49 | ✘ |
| 应付款项(万元) | 6,549.62 | 6,460.44 | 8,715.14 | 7,186.17 | 8,163.98 | ✘ |
| 长期借款(万元) | -- | -- | -- | -- | -- | ✔ |
| 未分配利润(万元) | 373,754.31 | 412,491.21 | 452,775.88 | 365,430.07 | 437,219.85 | ✔ |
| 商誉(万元) | 109.83 | 109.83 | 109.83 | 109.83 | 109.83 | ✔ |
| 流动资产(万元) | 171,075.69 | 189,831.59 | 225,973.62 | 206,851.84 | 194,459.84 | ✘ |
| 流动负债(万元) | 72,046.83 | 69,447.66 | 142,657.31 | 96,456.39 | 66,132.52 | ✔ |
华兰生物002007评分结果 | 54.55分 | 卖出/减持 | ||||